These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9578333)

  • 1. On the extrapyramidal side-effects of antipsychotics with combined dopamine and 5-HT-blocking effects.
    Sher L
    Med Hypotheses; 1998 Mar; 50(3):267-8. PubMed ID: 9578333
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.
    Nishimura K; Tsuka M; Horikawa N
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes.
    Casey DE
    Psychopharmacol Ser; 1993; 10():101-10. PubMed ID: 8103220
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
    Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 9. Extrapyramidal side-effects and antipsychotics: are second-generation agents still indicated?
    Temmingh HS
    Br J Psychiatry; 2012 Sep; 201(3):247; author reply 247-8. PubMed ID: 22945927
    [No Abstract]   [Full Text] [Related]  

  • 10. Aripiprazole's receptor pharmacology and extrapyramidal side effects.
    Poyurovsky M; Weizman R; Weizman A
    Am J Psychiatry; 2008 Mar; 165(3):398; author reply 398-9. PubMed ID: 18316435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone and neuroleptic malignant syndrome.
    Tarsy D
    JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypotension and orthostasis following a risperidone overdose.
    Himstreet JE; Daya M
    Ann Pharmacother; 1998 Feb; 32(2):267. PubMed ID: 9496415
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-HT2 antagonism and EPS benefits: is there a causal connection?
    Kapur S
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):35-9. PubMed ID: 8935798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
    Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.
    Lako IM; van den Heuvel ER; Knegtering H; Bruggeman R; Taxis K
    J Clin Psychopharmacol; 2013 Oct; 33(5):675-81. PubMed ID: 23948784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.
    Kamin J; Manwani S; Hughes D
    Psychiatr Serv; 2000 Mar; 51(3):287-9. PubMed ID: 10686232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.